A Prospective,Non-randomized Feasibility and Preliminary Efficacy Study of a Telemedicine-Enabled Co-management Intervention for Adults With Type 2 Diabetes and Moderate Anxiety and/or Depression
Restricted accessResearch articleFirst published online April, 2021
A Prospective,Non-randomized Feasibility and Preliminary Efficacy Study of a Telemedicine-Enabled Co-management Intervention for Adults With Type 2 Diabetes and Moderate Anxiety and/or Depression
The primary aim of this pilot study was to examine the feasibility of codelivering a mental health intervention with an evidence-based type 2 diabetes (T2DM) boot camp care management program. The preliminary impact of participation on symptom scores for depression and anxiety and A1C was also examined.
Methods
This was a 12-week, non-randomized pilot intervention conducted with a convenience sample of adults with uncontrolled T2DM and moderate depression and/or anxiety at an urban teaching hospital. Co-management intervention delivery was via in-person and telehealth visits. Participants were assessed at baseline and 90 days.
Results
Participants (n = 18) were African American, majority female (83%), and age 50.7 ± 13.4 years. Significant improvements in mental health outcomes were demonstrated, as measured by a reduction in Patient Health Questionnaire − 9 scores of 2.4 ± 2.9 (P = .01) and in Generalized Anxiety Disorder − 7 scores of 2.3 ± 1.9 (P = .001). The pre-post intervention mean A1C improved by 3.4 ± 2.1 units from 12% ± 1.4% to 8.5% ± 1.7% (P < .001).
Conclusion
The data generated in this pilot support the feasibility of delivering a diabetes and mental health co-management intervention using a combination of in-person and telemedicine visits to engage adults with T2DM and coexisting moderate depression and/or anxiety. Further research is warranted.
Get full access to this article
View all access options for this article.
References
1.
XuGLiuBSunY, et al. Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study. BMJ. 2018;361:k1497. doi:10.1136/bmj.k1497
2.
WardBWSchillerJS. Prevalence of multiple chronic conditions among US adults: estimates from the National Health Interview Survey, 2010. Prev Chronic Dis. 2013;10:E65. doi:10.5888/pcd10.120203
3.
ChenP-CChanYTChanHFKoMCLiC. Population-based cohort analyses of the bidirectional relationship between type 2 diabetes and depression. Diabetes Care. 2013;36(2):376-382. doi:10.2337/dc12-0473
4.
AndersonRJFreedlandKEClouseRELustmanPJ. The prevalence of comorbid depression in adults with diabetes. Diabetes Care. 2001;24(6):1069-1078.
5.
AliSStoneMAPetersJLDaviesMJKhuntiK. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006;23(11):1165-1173.
6.
KhalediMHaghighatdoostFFeiziAAminorroayaA. The prevalence of comorbid depression in patients with type 2 diabetes: an updated systematic review and meta-analysis on huge number of observational studies. Acta Diabetol. 2019;56(6):631-650. doi:10.1007/s00592-019-01295-9
7.
LiCBarkerLFordESZhangXStrineTWMokdadAH. Diabetes and anxiety in US adults: findings from the 2006 behavioral risk factor surveillance system. Diabet Med. 2008;25(7):878-881. doi:10.1111/j.1464-5491.2008.02477.x
8.
SmithKJDeschenesSSSchmitzN. Investigating the longitudinal association between diabetes and anxiety: a systematic review and meta-analysis. Diabet Med. 2018;35(6):677-693. doi:10.1111/dme.13606
9.
CollinsMMCorcoranPPerryIJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009;226(2):153-161. doi:10.1111/j.1464-5491.2008.02648.x
10.
SmithKJBélandMClydeM, et al. Assocation of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res. 2013;74(2):89-99. doi:10.1016/j.jpsychores.2012.11.013
11.
CiechanowskiPSKatonWJRussoJE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160(21):3278-3285.
12.
KatonWJRutterCSimonGE, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28(11):2668-2672.
13.
EgedeLEZhengDSimpsonK. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25(3):464-470.
14.
MasmoudiJDamakRZouariH, et al. Prevalence and impact of anxiety and depression on type 2 diabetes in Tunisian patients over sixty years old. Depress Res Treat. 2013;2013:341782. doi:10.1155/2013/341782
15.
SchramMTBaanCAPouwerF. Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Curr Diabetes Rev. 2009;5(2):112-119.
16.
AndersonRJGrigsbyABFreedlandKE, et al. Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med. 2002;32(3):235-247.
17.
de GrootMAndersonRFreedlandKEClouseRELustmanPJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63(4):619-630.
18.
NouwenAAdriaanseMvan DamK, et al. Longitudinal associations between depression and diabetes complications: a systematic review and meta-analysis. Diabet Med. 2019;36(12):1562-1572. doi:10.1111/dme.14054
19.
ElamoshyRBirdYThorpeLMorarosJ. Risk of depression and suicidality among diabetic patients: a systematic review and meta-analysis. J Clin Med. 2018;7(11):pii:E445. doi:10.3390/jcm7110445
20.
EgedeLE. Effect of depression on self-management behaviors and health outcomes in adults with type 2 diabetes. Curr Diabetes Rev. 2005;1(3):235-243.
21.
van DoorenFENegsGSchramMTVerheyFRDenolletJPouwerF. Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis. PLoS One. 2013;8(3):e57058. doi:10.1371/journal/pone.0057058
22.
HermannsNKulzerBKrichbaumMKubiakTHaakT. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia. 2006;49(3):469-477.
23.
American Diabetes Association. Facilitating behavior change and well-being to improve health outcomes: standards of medical care in diabetes - 2020. Diabetes Care. 2020;43(suppl 1):S48-S65. doi:10.2337/dc20-S005
24.
van der Feltz-CornelisCMNuyenJStoopC, et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2010;32:645.
25.
ButlerACChapmanJEFormanEMBeckAT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006;26(1):17-31.
26.
LustmanPJGriffithLSFreedlandKEKisselSSClouseRE. Cognitive behavior therapy for depression in type 2 diabetes mellitua. A randomized, controlled trial. Ann Intern Med. 1998;129(8): 613-621.
27.
de GrootMDoyleTAverytJ. Program ACTIVE: cognitive behavioral therapy to treat depresion in adults with type 2 diabetes in rural Appalachia. J Cogn Psychother. 2017;31(3):158-170. doi:10.1891/0889-8391.31.3.158
28.
de GrootMShubrookJHornsbyWGJr, et al. Program ACTIVE II: outcomes from a randomized, multistate community-based depression treatment for rural and urban adults with type 2 diabetes. Diabetes Care. 2019;42(7):1185-1193. doi:10.2337/dc/18-2400
29.
BeckAT. Cognitive Therapy and the Emotional Disorders. Penguin Books; 1976.
30.
BeckJS. Cognitive Therapy: Basics and Beyond. The Guilford Press; 1995.
31.
UchenduCBlakeH. Effectiveness of cognitive-behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes mellitus: a systematic review and meta-analysis of randomzied controlled trials. Diabet Med. 2017;34(3): 328-339. doi:10.1111/dme.13195
32.
LiCXuDHuM, et al. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for patients with diabetes and depression. J Psychosom Res. 2017;95:44-54. doi:10.1016.j.jpsychores.2017.02.006
33.
MageeMFBakerKMFernandezS, et al. Redesigning ambulatory care management for uncontrolled type 2 diabetes: a prospective cohort study of the impact of a boot camp model on outcomes. BMJ Open Diabetes Res Care. 2019;7(1):E000731. doi:10.1136/bmjdrc-2019-000731
34.
SpitzerRLKroenkeKWilliamsJ. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999;282(18):1737-1744.
35.
KroenkeKSpitzerRLWilliamsJB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9): 606-613.
36.
LöweBKroenkeKHerzogWGrafeK. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord. 2004;81(1):61-66.
37.
SpitzerRLKroenkeKWilliamsJBLöweB. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097.
38.
LöweBDeckerOMullerS, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46(3):266-274. doi:10.1097/MLR.0b013e318160d093
39.
MillerWRRollnickS. Motivational Interviewing: Helping People Change. 3rd ed.Guilford Press; 2013.
40.
CameronIMCrawfordJRLawtonKReidIC. Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care. Br J Gen Pract. 2008;58(546):32-36. doi:10.3399/bjgp08X263794
41.
MartinARiefWKlaibergABraehlerE. Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population. Gen Hosp Psychiatry. 2006;28(1):71-77.
42.
PietteJDRichardsonCHimleJ, et al. A randomized trial of telephone counseling plus walking for depressed diabetes patients. Med Care. 2011;49(7):641-648. doi:10.1097/MLR.0b013e318 215d0c9
43.
EgedeLEWalkerRJPayneEHKnappRGAciernoRFruehBC. Effect of psychotherapy for depression via home telehealth on glycemic control in adults with type 2 diabetes: subgroup analysis of a randomized clincial trial. J Telemed Telecare. 2018;24(9):596-602. doi:10.1177/1357633X17730419
44.
HuangYWeiXWuTChenRGuoA. Collaborative care for patients with depression and diabetes mellitus: a systematic review and meta-analysis. BMC Psychiatry. 2013;13:260. doi: 10.1186/1471-244x-13-260
45.
KaltmanSSerranoATalismanN, et al. Type 2 diabetes and depression: a pilot trial of an integrated self-management intervention for Latino immigrants. Diabetes Educator. 2016;42(1):87-95. doi:10.1177/0145721715617536
